-
Aygun G, Demirkiran O, Utku T, Mete B, Urkmez S, Yilmaz M, Yasar H, Dikmen Y, Ozturk R, 2002: Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit[J]. J Hosp Infect, 52, 259-262. doi: 10.1053/jhin.2002.1300
-
Bernards AT, Harinck HI, Dijkshoorn L, van der Reijden TJ, van den Broek PJ, 2004: Persistent Acinetobacter baumannii? Look inside your medical equipment[J]. Infect Control Hosp Epidemiol, 25, 1002-1004. doi: 10.1086/502335
-
Bonomo RA, Szabo D, 2006: Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J]. Clin Infect Dis, 43, S49-S56.
-
Bou G, Oliver A, Martinez-Beltran J, 2000: OXA-24 a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain[J]. Antimicrob Agents Chemother, 44, 1556-1561. doi: 10.1128/AAC.44.6.1556-1561.2000
-
Briers Y, Volckaert G, Cornelissen A, Lagaert S, Michiels CW, Hertveldt K, Lavigne R, 2007: Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL[J]. Mol Microbiol, 65, 1334-1344. doi: 10.1111/mmi.2007.65.issue-5
-
Centers for Disease Control and Prevention (CDC) (2004) Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 53: 1063-1066
-
Cha K, Oh HK, Jang JY, Jo Y, Kim WK, Ha GU, Ko KS, Myung H, 2018: Characterization of two novel bacteriophages infecting multidrug-resistant (MDR) Acinetobacter baumannii and evaluation of their therapeutic efficacy in vivo[J]. Front Microbiol, 10, 696-.
-
Clark JR, March JB, 2006: Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials[J]. Trends Biotechnol, 24, 212-218. doi: 10.1016/j.tibtech.2006.03.003
-
Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T, 2002: Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units[J]. J Hosp Infect, 50, 110-114. doi: 10.1053/jhin.2001.1127
-
Davis KA, Moran KA, McAllister CK, Gray PJ, 2005: Multidrug-resistant Acinetobacter extremity infections in soldiers[J]. Emerg Infect Dis, 11, 1218-1224. doi: 10.3201/1108.050103
-
De Jong G, Duse A, Richards G, Marais E, 2004: Back to basics: optimizing the use of available resources during an outbreak of multi-drug resistant Acinetobacter spp[J]. J Hosp Infect, 57, 186-187. doi: 10.1016/j.jhin.2004.03.012
-
Denton M, Wilcox MH, Parnell P, Green D, Keer V, Hawkey PM, Evans I, Murphy P, 2005: Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit[J]. Intensive Crit Care Nurs, 21, 94-98. doi: 10.1016/j.iccn.2003.10.008
-
Fournier PE, Richet H, 2006: The epidemiology and control of Acinetobacter baumannii in health care facilities[J]. Clin Infect Dis, 42, 692-699. doi: 10.1086/500202
-
Ghajavand H, Esfahani BN, Havaei A, Fazeli H, Jafari R, Moghim S, 2017: Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii[J]. Res Pharm Sci, 12, 373-380. doi: 10.4103/1735-5362.213982
-
Gkrania-Klotsas E, Hershow RC, 2006: Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality[J]. Clin Infect Dis, 43, 1224-1225. doi: 10.1086/508360
-
Górski A, Międzybrodzki R, Łobocka M, Głowacka-Rutkowska A, Bednarek A, Borysowski J, Jończyk-Matysiak E, Łusiak-Szelachowska M, Weber-Dąbrowska B, Bagińska N, Letkiewicz S, Dąbrowska K, Scheres J (2018) Phage therapy: what have we learned? Viruses 10: 288
-
Göttig S, Gruber TM, Higgins PG, Wachsmuth M, Seifert H, Kempf VA, 2014: Detection of pan drug-resistant Acinetobacter baumannii in Germany[J]. J Antimicrob Chemother, 69, 2578-2579. doi: 10.1093/jac/dku170
-
Hawley JS, Murray CK, Griffith ME, McElmeel ML, Fulcher LC, Hospenthal DR, Jorgensen JH, 2007: Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel[J]. Antimicrob Agents Chemother, 51, 376-378. doi: 10.1128/AAC.00858-06
-
Hernandez-Morales AC, Lessor LL, Wood TL, Migl D, Mijalis EM, Russell WK, Young RF, Gill JJ, 2018: Genomic and biochemical characterization of Acinetobacter podophage petty reveals a novel lysis mechanism and tail-associated depolymerase activity[J]. J Virol, 92, e01064-17.
-
Ho YH, Tseng CC, Wang LS, Chen YT, Ho GJ, Lil TY, Wang LY, Chen LK, 2016: Application of bacteriophage-containing aerosol against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii in an intensive care unit[J]. PLoS ONE, 11, e0168380-. doi: 10.1371/journal.pone.0168380
-
Hua Y, Luo T, Yang Y, Dong D, Wang R, Wang Y, Xu M, Guo X, Hu F, He P, 2018: Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice[J]. Front Microbiol, 8, 2659-. doi: 10.3389/fmicb.2017.02659
-
Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA, 2006: Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother[J]. Antimicrob Agents Chemother, 50, 4114-4123. doi: 10.1128/AAC.00778-06
-
Jasim HN, Hafidh RR, Abdulamir AS, 2018: Formation of therapeutic phage cocktail and endolysin to highly multi-drug resistant Acinetobacter baumannii: in vitro and in vivo study[J]. Iran J Basic Med Sci, 21, 1100-1108.
-
Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J, 2018: Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial[J]. Lancet Infect Dis, 19, 35-45.
-
Jawad A, Heritage J, Snelling AM, Gascoyne-Binzi DM, Hawkey PM, 1996: Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces[J]. J Clin Microbiol, 34, 2881-2887.
-
Jerassy Z, Yinnon AM, Mazouz-Cohen S, Benenson S, Schlesinger Y, Rudensky B, Raveh D, 2006: Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002[J]. J Hosp Infect, 62, 230-236. doi: 10.1016/j.jhin.2005.07.007
-
Jiang M, Mu Y, Li N, Zhang Z, Han S, 2018: Carbapenem-resistant Acinetobacter baumannii from air and patients of intensive care units[J]. Pol J Microbiol, 67, 333-338. doi: 10.21307/pjm-2018-040
-
Kusradze I, Karumidze N, Rigvava S, Dvalidze T, Katsitadze M, Amiranashvili GM, 2016: Characterization and testing the efficiency of Acinetobacter baumannii phage vB-GEC_Ab-M-G7 as an antibacterial agent[J]. Front Microbiol, 7, 1590-.
-
Kwon KT, Oh WS, Song JH, Chang HH, Jung SI, Kim SW, Ryu SY, Heo ST, Jung DS, Rhee JY, Shin SY, Ko KS, Peck KR, Lee NY, 2007: Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia[J]. J Antimicrob Chemother, 59, 525-530. doi: 10.1093/jac/dkl499
-
Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K, 2005: Evaluation of colistin as an agent against multi-resistant gram-negative bacteria[J]. Int J Antimicrob Agents, 25, 11-25. doi: 10.1016/j.ijantimicag.2004.10.001
-
Liu Y, Mi Z, Mi L, Huang Y, Li P, Liu H, Yuan X, Niu W, Jiang N, Bai C, Gao Z, 2019: Identification and characterization of capsule depolymerase Dpo48 from Acinetobacter baumannii phage IME200[J]. PeerJ, 7, e6173-. doi: 10.7717/peerj.6173
-
Maragakis LL, Cosgrove SE, Song X, Kim D, Rosenbaum P, Ciesla N, Srinivasan A, Ross T, Carroll K, Perl TM, 2004: An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment[J]. JAMA, 292, 3006-3011. doi: 10.1001/jama.292.24.3006
-
Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Ikeuchi M, Tani T, Fujieda M, Wakiguchi H, Imai S, 2005: Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases[J]. J Infect Chemother, 11, 211-219. doi: 10.1007/s10156-005-0408-9
-
Merabishvili M, Vandenheuvel D, Kropinski AM, Mast J, De Vos D, Verbeken G, Noben JP, Lavigne R, Vaneechoutte M, Pirnay JP, 2014: Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii[J]. PLoS ONE, 9, e104853-. doi: 10.1371/journal.pone.0104853
-
Międzybrodzki R, Borysowski J, Weber-Dąbrowska B, Fortuna W, Letkiewicz S, Szufnarowski K, Pawełczyk Z, Rogóż P, Kłak M, Wojtasik E, Górski A, 2012: Clinical aspects of phage therapy[J]. Adv Virus Res, 83, 73-121. doi: 10.1016/B978-0-12-394438-2.00003-7
-
Mussi MA, Limansky AS, Viale AM, 2005: Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins[J]. Antimicrob Agents Chemother, 49, 1432-1440. doi: 10.1128/AAC.49.4.1432-1440.2005
-
Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA, 2007: Global challenge of multidrug-resistant Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 51, 3471-3484. doi: 10.1128/AAC.01464-06
-
Podnos YD, Cinat ME, Wilson SE, Cooke J, Gornick W, Thrupp LD, 2001: Eradication of multi-drug resistant Acinetobacter from an intensive care unit[J]. Surg Infect (Larchmt), 2, 297-301. doi: 10.1089/10962960152813331
-
Rice LB, 2006: Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa[J]. Clin Infect Dis, 43, S100-S105.
-
Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M, 2006: The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes[J]. J Hosp Infect, 64, 282-287. doi: 10.1016/j.jhin.2006.06.025
-
Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T, 2017: Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection[J]. Antimicrob Agents Chemother, 61, e00954-17.
-
Seifert H, Strate A, Pulverer G, 1995: Nosocomial bacteremia due to Acinetobacter baumannii[J]. Clinical features, epidemiology, and predictors of mortality. Med (Baltim), 74, 340-349.
-
Soothill JS, 1992: Treatment of experimental infections of mice with bacteriophages[J]. J Med Microbiol, 37, 258-261. doi: 10.1099/00222615-37-4-258
-
Sulakvelidze A, Alavidze Z, Morris JG, 2001: Bacteriophage therapy[J]. Antimicrob Agents Chemother, 45, 649-659. doi: 10.1128/AAC.45.3.649-659.2001
-
Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A, 2007: Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization[J]. Emerg Infect Dis, 13, 97-103. doi: 10.3201/eid1301.060716
-
Thomson JM, Bonomo RA (2005) The threat of antibiotic resistance in gram-negative pathogenic bacteria: beta-lactams in peril! Curr Opin Microbiol 8: 518-524
-
Tomaras AP, Dorsey CW, Edelmann RE, Actis LA, 2003: Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system[J]. Microbiology, 149, 3473-3484. doi: 10.1099/mic.0.26541-0
-
Towner KJ, 2009: Acinetobacter: an old friend, but a new enemy[J]. J Hosp Infect, 7, 355-363.
-
Turner D, Wand ME, Briers Y, Lavigne R, Sutton JM, Reynolds DM, 2017: Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki[J]. PLoS ONE, 12, e0172303-. doi: 10.1371/journal.pone.0172303
-
van Helvoort T, 1992: Bacteriological and physiological research styles in the early controversy on the nature of the bacteriophage phenomenon[J]. Med Hist, 36, 243-270. doi: 10.1017/S0025727300055265
-
Villegas MV, Hartstein AI, 2003: Acinetobacter outbreaks, 1977-2000[J]. Infect Control Hosp Epidemiol, 24, 284-295. doi: 10.1086/502205
-
Wang JL, Kuo CF, Yeh CM, Chen JR, Cheng MF, Hung CH, 2018: Efficacy of phikm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection[J]. Infec Drug Resist, 11, 2301-2310. doi: 10.2147/IDR
-
Wilks M, Wilson A, Warwick S, Price E, Kennedy D, Ely A, Millar MR, 2006: Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation[J]. Infect Control Hosp Epidemiol, 27, 654-658. doi: 10.1086/507011
-
World Health Organization (WHO) (2018) WHO publishes list of bacteria for which new antibiotics are urgently needed. http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en. Assessed 14 Nov 2018
-
World Health Organization (WHO) (2019) Ten threats to global health in 2019. https://www.who.int/emergencies/ten-threats-to-global-health-in-2019. Assessed 18 Feb 2019
-
Wu M, Hu K, Xie Y, Liu Y, Mu D, Guo H, Zhang Z, Zhang Y, Chang D, Shi Y, 2019: A Novel phage PD-6A3, and its endolysin Ply6A3, with extended lytic activity against Acinetobacter baumannii[J]. Front Microbiol, 9, 3302-. doi: 10.3389/fmicb.2018.03302
-
Yang H, Liang L, Lin S, Jia S, 2010: Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii[J]. BMC Microbiol, 10, 131-. doi: 10.1186/1471-2180-10-131
-
Zanetti G, Blanc DS, Federli I, Raffoul W, Petignat C, Maravic P, Francioli P, Berger MM, 2007: Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination[J]. Infect Control Hosp Epidemiol, 28, 723-725. doi: 10.1086/517956
-
Zhang J, Liu X, Li XJ, 2015: Bioinformatic analysis of phage AB3, a phiKMV-like virus infecting Acinetobacter baumannii[J]. Genet Mol Res, 14, 190-198. doi: 10.4238/2015.January.16.2